title: Crystal structure of bis-[1-(2-hy-droxy-eth-yl)-2-methyl-5-nitro-1H-imidazole-κN (3)]silver(I) tetra-fluorido-borate methanol monosolvate.
abstract: 1-(2-Hy-droxy-eth-yl)-2-methyl-5-nitro-1H-imidazole (metronidazole, MET) is a medication that is used to treat infections by a variety of anaerobic organisms, but there are relatively few reports of the structures of metal compounds that exhibit coordination of metronidazole. We have demonstrated that MET reacts with AgBF4 to give [Ag(MET)2]BF4·CH3OH, in which the Ag(I) cation is coordinated by two MET ligands with a trans arrangement. The structure of [Ag(MET)2]BF4 exhibits some inter-esting differences from its nitrate counterpart, [Ag(MET)2]NO3 [Fun et al. (2008). Acta Cryst. E64, m668]. For instance, although the two MET ligands of both [Ag(MET)2]BF4 and [Ag(MET)2]NO3 are almost coplanar, the former compound has an anti-like geometry with a mol-ecular inversion center, but the latter has a syn-like arrangement. In the crystal, the BF4 (-) anion is linked by an O-H⋯F hydrogen bond to the methanol solvent molecule, which is, in turn, linked to the cation by an O-H⋯O hydrogen bond; the components of the structure are linked by O-H⋯O hydrogen bonds, forming chains along [001]. One of the MET ligands and the BF4 (-) anion are disordered over two sets of sites with ratios of refined occupancies 0.501 (17):0.499 (17) and 0.539 (19):0.461 (19), respectively.
authors.affiliation: Department of Chemistry, Columbia University, New York, NY 10027, USA.
authors.forename: Joshua H
authors.initials: JH
authors.lastname: Palmer
authors.affiliation: Haskins Laboratories, Dept. of Chemistry, Pace University, New York, NY 10038, USA.
authors.forename: Rita K
authors.initials: RK
authors.lastname: Upmacis
keywords: Flag­yl; crystal structure; hydrogen bonding; metronidazole; silver; tetra­fluorido­borate
references.citation: Pharmazie. 2014 Aug;69(8):571-7
references.pmid: 25158566
references.citation: Acta Crystallogr Sect E Struct Rep Online. 2012 Feb 1;68(Pt 2):m185-6
references.pmid: 22346857
references.citation: Clin Infect Dis. 2010 Jan 1;50 Suppl 1:S16-23
references.pmid: 20067388
references.citation: Chem Biodivers. 2005 Oct;2(10):1320-30
references.pmid: 17191933
references.citation: Drugs. 1997 Nov;54(5):679-708
references.pmid: 9360057
references.citation: Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22
references.pmid: 18156677
references.citation: J Appl Oral Sci. 2012 May-Jun;20(3):295-309
references.pmid: 22858695
references.citation: Antimicrob Agents Chemother. 1999 Jul;43(7):1533-41
references.pmid: 10390199
references.citation: Acta Crystallogr Sect E Struct Rep Online. 2008 Apr 16;64(Pt 5):m668-9
references.pmid: 21202210
references.citation: J Inorg Biochem. 2002 Jul 25;91(1):339-48
references.pmid: 12121793
references.citation: J Inorg Biochem. 2006 Dec;100(12):1974-82
references.pmid: 16938347
references.citation: Inorg Chem. 2003 Nov 17;42(23):7579-86
references.pmid: 14606854